We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-12.43%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$73.9B
AUM Growth
-$12.4B
(-14%)
Cap. Flow
-$7.83B
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
2,664
New
311
Increased
910
Reduced
656
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$788M |
| 2 |
Union Pacific
UNP
|
+$641M |
| 3 |
Icon
ICLR
|
+$463M |
| 4 |
Wells Fargo
WFC
|
+$310M |
| 5 |
CSX Corp
CSX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$599M |
| 2 |
Intercontinental Exchange
ICE
|
+$280M |
| 3 |
PepsiCo
PEP
|
+$246M |
| 4 |
FedEx
FDX
|
+$242M |
| 5 |
Colgate-Palmolive
CL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.51% |
| 2 | Healthcare | 14.98% |
| 3 | Financials | 13.27% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
TriplePoint Venture Growth BDC
TPVG
$193M
| $62K | ﹤0.01% |
4,887
+2,652
| +119% | +$40K |
|
1502
World Kinect Corp
WKC
$2B
| $62K | ﹤0.01% |
3,061
+703
| +30% | +$17.3K |
|
|
SMAR
1503
DELISTED
Smartsheet Inc.
SMAR
| $62K | ﹤0.01% |
2,004
+619
| +45% | +$25.6K |
|
1504
MetroCity Bankshares
MCBS
$1.03B
| $61K | ﹤0.01% |
3,047
+1,552
| +104% | +$32.1K |
|
1505
Arcus Biosciences
RCUS
$3.62B
| $61K | ﹤0.01% |
2,436
| – | – |
|
1506
SITE Centers
SITC
$166M
| $61K | ﹤0.01% |
5,845
| – | – |
|
1507
Southwest Gas
SWX
$6.44B
| $61K | ﹤0.01% |
704
-110,649
| -99% | -$9.76M |
|
|
ABST
1508
DELISTED
Absolute Software Corp
ABST
| $61K | ﹤0.01% |
7,140
+2,679
| +60% | +$22.4K |
|
1509
Corcept Therapeutics
CORT
$11.9B
| $60K | ﹤0.01% |
2,530
+2,424
| +2,287% | +$52.8K |
|
1510
Griffon
GFF
$4.29B
| $60K | ﹤0.01% |
+2,144
| New | +$54.1K |
|
|
PPLI
1511
People Inc
PPLI
$3.45B
| $60K | ﹤0.01% |
975
| – | – |
|
1512
NRC Health Common Stock
NRC
$434M
| $60K | ﹤0.01% |
1,586
+338
| +27% | +$12.2K |
|
1513
RCM Technologies
RCMT
$204M
| $60K | ﹤0.01% |
+3,001
| New | +$56.8K |
|
1514
Voyager Therapeutics
VYGR
$189M
| $60K | ﹤0.01% |
10,283
-7,395
| -42% | -$50K |
|
1515
Anika Therapeutics
ANIK
$262M
| $59K | ﹤0.01% |
+2,651
| New | +$59.1K |
|
|
CHCT
1516
Community Healthcare Trust
CHCT
$506M
| $59K | ﹤0.01% |
1,654
+978
| +145% | +$36.6K |
|
1517
Coherus Oncology
CHRS
$228M
| $59K | ﹤0.01% |
8,222
-14,666
| -64% | -$128K |
|
1518
Vaalco Energy
EGY
$551M
| $59K | ﹤0.01% |
8,520
+7,760
| +1,021% | +$55.5K |
|
|
KYNB
1519
Kyntra Bio
KYNB
$28M
| $59K | ﹤0.01% |
+225
| New | +$57.5K |
|
1520
Kite Realty
KRG
$5.59B
| $59K | ﹤0.01% |
3,444
+1,436
| +72% | +$29.7K |
|
|
LOVE
1521
LoveSac
LOVE
$266M
| $59K | ﹤0.01% |
+2,151
| New | +$83.6K |
|
1522
Q2 Holdings
QTWO
$3.99B
| $59K | ﹤0.01% |
1,537
+547
| +55% | +$26.6K |
|
|
DM
1523
DELISTED
Desktop Metal, Inc.
DM
| $59K | ﹤0.01% |
+2,690
| New | +$78.7K |
|
|
AERI
1524
DELISTED
Aerie Pharmaceuticals
AERI
| $59K | ﹤0.01% |
+7,877
| New | +$55.5K |
|
1525
Albemarle
ALB
$14.2B
| $58K | ﹤0.01% |
282
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Lazard Asset Management held 2,664 positions worth $73.9B, down 14% from $86.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $7.83B in Q2 2022, closing 240 positions and reducing 656 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $74.1M.
- Lazard Asset Management's largest Q2 2022 buy was Aspen Technology Inc: 403,325 shares worth $74.1M.
- Lazard Asset Management added most to Norfolk Southern in Q2 2022, an estimated $788M increase.
- Lazard Asset Management's biggest Q2 2022 reduction was Medtronic, cutting an estimated $599M.
- Lazard Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $156M.
- Lazard Asset Management's ten largest holdings make up 22% of its $73.9B portfolio in Q2 2022.
- Lazard Asset Management opened 311 new positions and closed 240 in Q2 2022.
- Lazard Asset Management's portfolio value fell 14% quarter-over-quarter to $73.9B.
Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.